Homocysteine and B-group vitamins in renal transplant patients

Clin Chim Acta. 1999 Apr;282(1-2):157-66. doi: 10.1016/s0009-8981(99)00023-6.

Abstract

Increased plasma homocysteine is an independent risk factor for cardiovascular disease. We have investigated homocysteine and B-group vitamin levels in renal transplant patients. Fasting blood was collected from 55 renal transplant recipients with good renal function and 32 age/sex matched control subjects. Total homocysteine was increased in transplant recipients in comparison to controls (10.9+/-1.5 vs. 6.7+/-1.3 micromol/l, P < 0.001). There was no difference in homocysteine between patients receiving cyclosporin (n = 39, homocysteine 11.0+/-1.5 micromol/l) and patients receiving prednisolone + azathioprine (n = 16, 10.8+/-1.6 micromol/l, mean+/-S.D.), although there was a significant correlation between homocysteine and serum cyclosporin concentration in the sub-group of patients receiving that immunosuppressive regimen (r = 0.42, P < 0.05). Levels of B-group vitamins were similar in patients and controls. Plasma homocysteine is increased in renal transplant recipients even in the presence of minor degrees of renal impairment and normal levels of B-group vitamins.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Female
  • Graft Rejection / prevention & control
  • Homocysteine / blood*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Models, Chemical
  • Prednisolone / therapeutic use
  • Vitamin B Complex / blood*

Substances

  • Immunosuppressive Agents
  • Homocysteine
  • Vitamin B Complex
  • Cyclosporine
  • Prednisolone
  • Azathioprine